NEW YORK (GenomeWeb News) – German molecular diagnostics firm SIRS-Lab said today that it will use a PCR technology platform from DxS in a sepsis pathogen-detection test in the European Union under a new licensing agreement.
SIRS-Lab will use the DxS Scorpions Technology with its Signature sepsis prediction and monitoring test, which it plans to make widely available in the EU in 2009. The companies also have agreed to include an option in the license that would allow SIRS-Lab to use the DxS PCR technology worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.